Michael Hadem

Part of Eurofins Scientific SE, Eurofins Genomics Germany GmbH is a leading genomics services provider worldwide. The company is based in Ebersberg, Germany. Eurofins Genomics offers various platforms for genotyping, as well as genomic services such as NGS, gene expression, sanger sequencing, oligonucleotides, and gene synthesis. The German company also provides biomarker discovery services for disease diagnostics and therapeutic targets. Eurofins Genomics also offers SARS-CoV-2 research support. The company was founded in 1990, and Michael Hadem has been the CEO of the company since 2016.